Latest news with #EUGMP
Business Standard
6 days ago
- Business
- Business Standard
Indoco Remedies edges higher after receiving EU GMP certificate for Goa-based manufacturing facility
Indoco Remedies rose 2.35% to Rs 317.35 after the company announced the receipt of certificate for EU Good Manufacturing Practices (GMP) compliance from the European Health Authorities for its sterile drug product manufacturing facility Goa Plant II. The said unit is located at L32, 33 and 34, Verna Industrial Estate, South Goa. The EU GMP certification issued by the European Health Authorities confirms that the site complies with the good manufacturing practice requirements. Aditi Panandikar, managing director, Indoco Remedies, said: "This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies. We remain fully committed to adhering to cGMP standards and consistently delivering quality products to customers and patients worldwide." Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company had reported a consolidated net loss of Rs 40.39 crore in the quarter ended March 2025 as against net profit of Rs 22.70 crore during the previous quarter ended March 2024. Sales declined by 12.57% to Rs 383.89 crore in Q4 FY25 over Q4 FY24.
Hamilton Spectator
6 days ago
- Business
- Hamilton Spectator
Pure Sunfarms Rolls Out New Windowed Packaging
DELTA, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) — Pure Sunfarms Corp. ('Pure Sunfarms'), a wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF) and one of Canada's leading cannabis producers, is proud to be the first licensed producer to introduce windowed packaging at scale across Pure Sunfarms' brand dried flower formats (7g, 14g, and 28g). This innovative approach marks a new era of cannabis shopping, one that empowers consumers to look beyond potency numbers and see the flower in the package before purchase. 'This isn't simply a packaging update. It's a shift in how we think about cannabis quality,' says Orville Bovenschen, President of Village Farms Canadian Cannabis. 'The plant is so much more than THC, but consumers have been asked to judge quality based on that number for too long. Real quality is something you can see: the structure of the bud, trichome coverage, the precision of the trim. That's what sets great flower apart, and now our customers can look at it for themselves.' This move follows recent regulatory changes from Health Canada allowing producers to use transparent immediate containers and cut-out windows for dried flower packaging. Pure Sunfarms seized the opportunity to innovate, creating a window that's both functional and protective. The result is a fully customized bag with multi-layer construction, designed to maintain freshness and quality while giving consumers a clear view of what's inside. 'Our commitment has always been to our consumers,' adds Bovenschen. 'They've already experienced a positive difference with our dried flower, and now they can make even more informed choices in-store. We're proud to be the first licensed producer to lead with this next step at scale in the evolution of Canadian cannabis.' The new packaging is currently being rolled out across Canada. As with any packaging update, consumers can expect to see it phased in gradually as new inventory arrives in stores. About Pure Sunfarms Pure Sunfarms is a global leader in cultivation, operating one of the largest cannabis facilities in the world. With a focus on high-quality B.C. grown cannabis, the company combines decades of agricultural and legacy experience with large-scale operational excellence in its state-of-the-art greenhouses located in Delta, British Columbia. Known as a top-selling brand of recreational dried flower across Canada, as well as a top licensed producer, Pure Sunfarms is renowned for producing popular cultivars like its Pink Kush. Pure Sunfarms products are currently available across Canada. The company also produces cannabis products for other licensed producers in Canada and maintains EU GMP certification for exports to medicinal markets internationally. Pure Sunfarms is the licensed producer of record for Pure Sunfarms, The Original Fraser Valley Weed Co., Soar, and Super Toast. Pure Sunfarms is a wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF). About Village Farms International Village Farms leverages decades of experience in Controlled Environment Agriculture as a large-scale, vertically-integrated supplier of high-value, high-growth plant-based Consumer Packaged Goods. The Company built a strong foundation as the leading and longest-tenured fresh produce supplier to grocery and large-format retailers throughout the US and Canada, but now focuses its agricultural expertise on high-growth cannabinoid opportunities internationally. In Canada, the Company's wholly owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world (2.2 million square feet of greenhouse production), the lowest-cost producer and one of Canada's best-selling brands. The Company owns an incremental 2.6 million square feet of greenhouse capacity in Canada for future expansion, and also owns 80% of Québec-based, Rose LifeScience, a leader in the commercialization of cannabis products. Internationally, Village Farms is targeting selected, nascent, legal cannabis opportunities with significant growth potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to international markets including Germany, the United Kingdom, Israel, Australia, and New Zealand. The Company is expanding its export business to new countries and customers, and making select investments in international production assets. In Europe, wholly-owned Leli Holland has one of 10 licenses to grow and distribute recreational cannabis within the Dutch Coffee Shop Experiment. In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US THC market via multiple strategies, leveraging its Texas-based greenhouse assets (2.2 million square feet of existing greenhouse capacity and 950 acres of owned, unoccupied land for future expansion). Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates renewable natural gas from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated. This partnership reduces Vancouver's greenhouse gas emissions by 475,000 metric tons of CO2 per year, equivalent to removing more than 100,000 vehicles off the road or the energy use equivalent of powering 51,300 homes for one year. The Company also holds a 37.9 percent equity ownership interest in Vanguard Food LP, a privately held joint venture with private investment firms which seeks to create a premier branded CPG foods company through M&A. Vanguard Food LP expects to continue acquiring other produce assets and operations with the support of its private investment firm partners, and will review various products and companies across many production methods while expanding its platform. Media Contact Danielle Allore media@ A photo accompanying this announcement is available at
Business Upturn
18-07-2025
- Business
- Business Upturn
Concord Biotech completes EU GMP inspection at Dholka API facility
By Aditya Bhagchandani Published on July 18, 2025, 13:10 IST Shares of Concord Biotech may remain in focus after the company announced that it has successfully completed the European Union Good Manufacturing Practice (EU GMP) inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in Dholka, Gujarat. In a regulatory filing on July 18, 2025, the company informed the exchanges that the inspection at the Dholka facility was conducted from July 14 to July 18, 2025. The audit was concluded without any critical observations, reflecting the company's adherence to global regulatory standards. 'This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of our operations. It reflects our dedication to excellence and our continued focus on meeting the rigorous requirements of global regulatory authorities,' the company said in the statement. The EU GMP certification is considered a key milestone for pharmaceutical companies, enabling them to export APIs to regulated markets in Europe and beyond. Hina Patel, Company Secretary and Compliance Officer of Concord Biotech, signed off the communication, which was addressed to both the National Stock Exchange of India and the BSE Limited. Investors and market participants will watch the stock closely as the EU GMP certification strengthens Concord Biotech's position in international markets and reinforces confidence in its manufacturing quality. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Standard
18-06-2025
- Business
- Business Standard
Sakar Healthcare surges after receiving marketing authorization in EU for its oncology product
Sakar Healthcare jumped 4.65% to Rs 344.20 after the company announced the receipt of second marketing authorization (MA) of oncology injection (product registration) for the European Union (EU). The companys dossier compiled under EU guidelines have fetched this second approval in continuation to the journey of their research-driven API-integrated EU GMP approved oncology formulation manufacturing unit. While the earlier product intends to treating breast cancer, non-small cell lung cancer and prostate cancer, this second one is for treating colorectal cancer; both are widely prevalent type of cancers. "Strategically the second MA now widens the door to export and commercialise injection products to the European countries, with the first MA that received approval in April-2025 is in process of its FIRST commercial supply, Sakar Healthcare stated. It further said that with another few products (mix of liquid, lyophilised injections and oral solids) presently under registration in the EU, the company expects the grant of these MAs one-by-one within next few months. These MAs will speed up the export of multiple oncology products to the EU region manufactured at Sakars state-of-the-art vertically integrated oncology product manufacturing site. Sakar Healthcare manufactures pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injections and syrups. The company manufactures generic formulations in 24 therapeutic categories, such as antibiotics, cough preparations, vitamins and mineral supplements, among others. Also, the company entered the oncology drugs segment with units for oncology formulations, APIs and injectables. The company's consolidated net profit surged 84.62% to Rs 5.76 crore as revenues increased by 16.67% to Rs 50.24 crore in Q4 FY25 as compared with Q4 FY24.
Yahoo
14-06-2025
- Business
- Yahoo
Medipharm announces Glass Lewis recommends shareholders vote for all nominees
MediPharm Labs (MEDIF) announced that independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. published a report on June 12 recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form FOR the Company's nominees for the Board of Directors at the upcoming Annual and Special Meeting of Shareholders on June 16. Glass Lewis is the second independent proxy advisory firm to recommend voting for the Company's nominees for the Board, following a similar recommendation issued by Institutional Shareholder Services on May 30. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on MEDIF: Disclaimer & DisclosureReport an Issue MediPharm Labs Advocates for Current Strategy Amid Shareholder Vote MediPharm Labs Wins Court Dismissal, Ensures Fair Shareholder Meeting Apollo releases investor presentation on plan for Medipharm Labs MediPharm Labs Sells Hope Facility and Expands EU GMP Cultivation Medipharm Labs closes sale of Hope facility, plans to expand Napanee capacity
